Paper Details

  1. Home
  2. Paper Details

A review of heart failure treatment.

Author: DevereauxP J, GuyattGordon H

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Heart failure has high mortality rates (10-40%). ACE inhibitors and beta-blockers are effective in reducing mortality, while spironolactone helps reduce mortality in patients with severe heart failure.
Paper Details　
Original Abstract of the Article :
Heart failure is a common and costly medical condition. Ischemic heart disease and hypertension account for most cases of heart failure in developed countries. Estimates of the one-year mortality rates for patients with New York Heart Association (NYHA) Class II, III, and IV are 10%, 20%, and 40%, r...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/14770250

データ提供：米国国立医学図書館（NLM）

Navigating the Shifting Sands of Heart Failure Treatment

Heart failure is a complex and challenging condition, often likened to a desert oasis slowly drying up. This review article explores the vast landscape of heart failure treatment, summarizing the evidence-based recommendations for managing this condition. The authors delve into the various medications and therapies used to address the symptoms and progression of heart failure, with a focus on their effectiveness and safety.

A Mosaic of Treatment Options: ACE Inhibitors, ARBs, Beta-blockers, and More

The authors highlight the significant benefits of angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) in reducing mortality and hospitalizations among heart failure patients. They also discuss the importance of beta-blockers in improving survival and the role of spironolactone in reducing mortality in patients with advanced heart failure. This review presents a comprehensive overview of the current therapeutic landscape for heart failure, emphasizing the importance of individualized treatment approaches.

A Roadmap to Better Heart Health

This review provides valuable insights into the management of heart failure, emphasizing the importance of early diagnosis, proactive lifestyle modifications, and evidence-based treatment strategies. It highlights the role of medication in improving symptoms, prolonging survival, and improving overall quality of life. By understanding the nuances of heart failure treatment, healthcare providers can navigate the complex landscape of this condition, offering patients a path towards better heart health.

Dr.Camel's Conclusion

Heart failure treatment is a complex journey, much like traversing a vast and unforgiving desert. This review provides a roadmap, guiding us through the different treatment options and their potential benefits. By understanding the effectiveness and safety of various medications and therapies, we can work together with patients to create a personalized path towards better heart health.

Date :
  1. Date Completed 2004-03-08
  2. Date Revised 2007-11-15
Further Info :

Pubmed ID

14770250

DOI: Digital Object Identifier

14770250

Related Literature

Article Analysis
・Side Effects of hydralazine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.